Subscribe now

Is Alzheimer’s drug donanemab really a 'turning point' for treatment?

18 July 2023

The experimental drug donanemab slows the progression of Alzheimer's disease compared with a placebo, but the effect may not be large enough to be noticed by people with the condition or their families


Mandatory Credit: Photo by EPA-EFE/Shutterstock (13842171a) Packages of prescribtion drugs Ozempic and Wegovy by Novo Nordisk sit on a table in Copenhagen, Denmark, 23 March 2023. US celebrities have credited their weight loss to the FDA-approved medications that are prescribed to treat Type 2 diabetes. Diabetes drugs used as slimming agent, Copenhagen, Denmark - 23 Mar 2023

People think drugs like Wegovy are a quick fix. So what if they are?

12 July 2023

Ideas that people should lose weight “the hard way” rather than take semaglutide drugs like Ozempic and Wegovy are holding back progress in the fight against obesity


Opioids no better than placebo for short-term lower back and neck pain

28 June 2023

People who took the opioid oxycodone or a placebo for six weeks reported similar pain scores for acute discomfort in their lower back or neck


Methylphenidate, often sold under the brand name Ritalin, can be prescribed to people with ADHD

'Smart drugs' don't make people better at a problem-solving test

14 June 2023

Some students take medicines like methylphenidate, often sold under the brand name Ritalin, to boost their performance before an exam, but research shows these drugs don't improve how well people do in tests


Diabetes drug metformin may cut the risk of long covid by 41 per cent

9 June 2023

Metformin, which is commonly used to control blood sugar levels in people with type 2 diabetes, was more effective than placebo at preventing lingering complications 10 months after a coronavirus infection


Do new Alzheimer's drugs signal the end of the condition?

24 May 2023

Antibody treatments that target amyloid plaques in the brains of people with Alzheimer's have shown promise in trials, but questions about their side effects and practicality remain


SARS-CoV-2 could evolve into new variants that may evade existing vaccines

Inhaled powder that coats airways can block coronavirus infection

9 February 2023

A gel that lines the respiratory tract prevented coronavirus infections in mice and monkeys, and may also work against any future new variants


The omicron coronavirus variant binding to a cell's ACE2 receptor

Drug that targets ACE2 receptors may work against new covid variants

5 December 2022

A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to


Our balance naturally declines with age, making serious falls more likely to occur

A daily dose of aspirin raises the risk of falls among older people

7 November 2022

In a trial of more than 16,000 people over 70, those who took a low-dose of aspirin every day were just under 10 per cent more likely to have a fall that required hospital care than those on placebo


Packets of drugs in woman's hands

Drugs that mutate viruses to kill them could make them more dangerous

26 August 2022

Several antiviral drugs kill viruses by inducing lots of mutations, but a computer model suggests this could have unpredictable consequences


Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop